Curious timing by ACHN—one day after the announcement of the CEO's "retirement".
VRTX was behind the curve when they licensed their nukes from Alios years ago. By the time ACHN figures it all out there won't be any HCV patients left in developed markets.
Market Data 
Markets 
AI
